KR100880859B1 - 자발분산성 n-벤조일-스타우로스포린 조성물 - Google Patents
자발분산성 n-벤조일-스타우로스포린 조성물 Download PDFInfo
- Publication number
- KR100880859B1 KR100880859B1 KR1020017009391A KR20017009391A KR100880859B1 KR 100880859 B1 KR100880859 B1 KR 100880859B1 KR 1020017009391 A KR1020017009391 A KR 1020017009391A KR 20017009391 A KR20017009391 A KR 20017009391A KR 100880859 B1 KR100880859 B1 KR 100880859B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- benzoyl
- composition
- staurosporin
- present
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/553—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one oxygen as ring hetero atoms, e.g. loxapine, staurosporine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Biophysics (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
I | II | III | IV | ||
공-/계면활성제 %(g/g) | 크레모포르 RH40 | 42.750 | 66.500 | 57.000 | |
솔루톨 HS 15 | 75.905 | ||||
라브라필 M2125 CS | 18.905 | ||||
친수성 성분%(g/g) | PEG 400 | 25.65 | |||
프로필렌 글리콜 | 9.500 | 4.750 | 9.500 | ||
에탄올 추출물 | 9.500 | 9.500 | |||
트리에틸시트레이트 | 4.750 | ||||
친유성 성분%(g/g) | 옥수수 오일 글리세라이드 | 17.005 | 28.405 | ||
다른 첨가제%(g/g) | 토코페롤 | 0.095 | 0.095 | 0.095 | 0.095 |
활성제%(g/g) | 5.000 | 5.000 | 5.000 | 5.000 | |
합계 | 100.0 | 100.0 | 100.0 | ||
평균입자크기(nm) | 31.6 | 20.4 | 66.3 | 157.3 |
Claims (23)
- 삭제
- 삭제
- 1) 0 중량% 초과 20중량% 이하의 N-벤조일-스타우로스포린,2) 5 내지 50중량%의 친수성 성분, 및3) 계면 활성제로서 5 내지 80중량%의, 14 내지 16의 HLB 값을 갖는 폴리옥시에틸렌 피마자유(castor oil) 유도체를 포함하는 경구 투여용 자발분산성 약제 조성물.
- 제 3항에 있어서, 친유성 성분을 포함하는 조성물.
- 제 4항에 있어서, 친수성 성분이 1,2-프로필렌 글리콜 또는 폴리에틸렌 글리콜인 조성물.
- 삭제
- 삭제
- 삭제
- 제 5항에 있어서, 조성물이 10 미만의 HLB 값을 갖는 공-계면 활성제를 추가로 포함하는 조성물.
- 제 9항에 있어서, 조성물이 공-계면 활성제로서 트랜스에스테르화된 에톡시화 식물성 오일을 포함하는 조성물.
- 제 5항에 있어서, 친유성 성분으로서 지방산 글리세라이드를 포함하는 조성물.
- 삭제
- (a) 0 중량% 초과 20중량% 이하의 N-벤조일-스타우로스포린,(b) 5 내지 50중량%의 친수성 성분,(c) 계면 활성제로서 5 내지 80중량%의, 14 내지 16의 HLB 값을 갖는 폴리옥시에틸렌 피마자유(castor oil) 유도체,(d) 5 내지 85중량%의 친유성 성분, 및(e) 0.05 내지 5중량%의 첨가제를 포함하는 경구 투여용 자발분산성 약제 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9903547.9 | 1999-02-16 | ||
GBGB9903547.9A GB9903547D0 (en) | 1999-02-16 | 1999-02-16 | Organic compounds |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020087015449A Division KR20080064914A (ko) | 1999-02-16 | 2000-02-14 | 자발분산성 n-벤조일-스타우로스포린 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010093281A KR20010093281A (ko) | 2001-10-27 |
KR100880859B1 true KR100880859B1 (ko) | 2009-01-30 |
Family
ID=10847896
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020017009391A KR100880859B1 (ko) | 1999-02-16 | 2000-02-14 | 자발분산성 n-벤조일-스타우로스포린 조성물 |
KR1020087015449A KR20080064914A (ko) | 1999-02-16 | 2000-02-14 | 자발분산성 n-벤조일-스타우로스포린 조성물 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020087015449A KR20080064914A (ko) | 1999-02-16 | 2000-02-14 | 자발분산성 n-벤조일-스타우로스포린 조성물 |
Country Status (34)
Country | Link |
---|---|
US (3) | US20020061873A1 (ko) |
EP (1) | EP1152750B1 (ko) |
JP (2) | JP5057610B2 (ko) |
KR (2) | KR100880859B1 (ko) |
CN (1) | CN100367930C (ko) |
AR (2) | AR022589A1 (ko) |
AT (1) | ATE430554T1 (ko) |
AU (1) | AU765776B2 (ko) |
BR (1) | BRPI0008228B8 (ko) |
CA (1) | CA2362277C (ko) |
CL (1) | CL2009001682A1 (ko) |
CZ (1) | CZ303979B6 (ko) |
DE (1) | DE60042151D1 (ko) |
DK (1) | DK1152750T3 (ko) |
EC (1) | ECSP083351A (ko) |
ES (1) | ES2326783T3 (ko) |
GB (1) | GB9903547D0 (ko) |
HK (1) | HK1045807B (ko) |
HU (1) | HUP0105364A3 (ko) |
ID (1) | ID30504A (ko) |
IL (3) | IL144512A0 (ko) |
MY (1) | MY128362A (ko) |
NO (1) | NO331232B1 (ko) |
NZ (1) | NZ513529A (ko) |
PE (1) | PE20001499A1 (ko) |
PL (1) | PL198330B1 (ko) |
PT (1) | PT1152750E (ko) |
RU (1) | RU2266121C2 (ko) |
SI (1) | SI1152750T1 (ko) |
SK (1) | SK286967B6 (ko) |
TR (1) | TR200102385T2 (ko) |
TW (1) | TWI240636B (ko) |
WO (1) | WO2000048571A1 (ko) |
ZA (1) | ZA200106677B (ko) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7795246B2 (en) | 1998-08-06 | 2010-09-14 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
US6200968B1 (en) * | 1998-08-06 | 2001-03-13 | Cephalon, Inc. | Particle-forming compositions containing fused pyrrolocarbazoles |
ES2261671T3 (es) * | 2001-03-26 | 2006-11-16 | Novartis Ag | Mezcla farmaceutica que incluye una estaurosporina poco soluble en agua, un surfactante y un polimero soluble en agua. |
JP4477303B2 (ja) | 2001-05-16 | 2010-06-09 | ノバルティス アーゲー | N−{5−[4−(4−メチル−ピペラジノ−メチル)−ベンゾイルアミド]−2−メチルフェニル}−4−(3−ピリジル)−2−ピリミジン−アミンおよび化学療法剤を含んでなる併用剤 |
KR20090087139A (ko) * | 2001-10-30 | 2009-08-14 | 노파르티스 아게 | Flt3 수용체 티로신 키나아제 활성의 억제제로서의 스타우로스포린 유도체 |
GB0206215D0 (en) | 2002-03-15 | 2002-05-01 | Novartis Ag | Organic compounds |
WO2004009056A1 (en) * | 2002-07-23 | 2004-01-29 | Novartis Ag | Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent |
US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
TWI324604B (en) * | 2003-06-18 | 2010-05-11 | Novartis Ag | New use of staurosporine derivatives |
GB0512324D0 (en) | 2005-06-16 | 2005-07-27 | Novartis Ag | Organic compounds |
GB0419159D0 (en) * | 2004-08-27 | 2004-09-29 | Novartis Ag | Organic compounds |
GT200500310A (es) | 2004-11-19 | 2006-06-19 | Compuestos organicos | |
US20100038816A1 (en) | 2006-08-16 | 2010-02-18 | Novartis Ag | Method of making solid dispersions of highly crystalline therapeutic compounds |
FR2918566B1 (fr) | 2007-07-11 | 2009-10-09 | Pierre Fabre Medicament Sa | Composition pharmaceutique stable d'un sel hydrosoluble de vinflunine. |
US20090155352A1 (en) * | 2007-11-20 | 2009-06-18 | Cephalon, Inc. | Microemulsion containing indolocarbazole compound and dosage forms containing the same |
EP2229936B1 (en) * | 2009-03-09 | 2015-05-06 | PharmaSol GmbH | Nanonized testosterone formulations for improved bioavailability |
WO2011000811A2 (en) * | 2009-06-30 | 2011-01-06 | Novartis Ag | Organic compounds |
RU2560677C2 (ru) * | 2009-12-22 | 2015-08-20 | Лео Фарма А/С | Кожная композиция, включающая аналог витамина d и смесь растворителя и поверхностно-активных веществ |
JO3337B1 (ar) | 2010-12-13 | 2019-03-13 | Debiopharm Sa | تركيبات صيدلية تشمل أليسبوريفير |
US9387446B2 (en) | 2011-09-22 | 2016-07-12 | Ariel-University Research And Development Company Ltd. | Emulsions and methods of making emulsions |
KR20190032265A (ko) * | 2015-12-09 | 2019-03-27 | 포스파제닉스 리미티드 | 약제학적 제형 |
CN108601732A (zh) | 2015-12-09 | 2018-09-28 | 磷肌酸有限公司 | 药物制剂 |
MX2019006845A (es) | 2016-12-21 | 2019-10-15 | Avecho Biotechnology Ltd | Proceso. |
US20220395553A1 (en) | 2019-11-14 | 2022-12-15 | Cohbar, Inc. | Cxcr4 antagonist peptides |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0657164A1 (en) * | 1993-12-11 | 1995-06-14 | Ciba-Geigy Ag | Pharmaceutical compositions containing staurosphorine derivatives |
EP0733358A2 (de) * | 1995-03-21 | 1996-09-25 | Ciba-Geigy Ag | Intravenös applizierbare Nanosuspensionen |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4963367A (en) | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US4735939A (en) * | 1987-02-27 | 1988-04-05 | The Dow Chemical Company | Insecticidal activity of staurosporine |
US5093330A (en) * | 1987-06-15 | 1992-03-03 | Ciba-Geigy Corporation | Staurosporine derivatives substituted at methylamino nitrogen |
DE3824034C1 (ko) * | 1988-07-15 | 1989-09-14 | Gustav 7290 Freudenstadt De Memminger | |
KR0148748B1 (ko) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | 사이클로스포린을 함유하는 약학조성물 |
EP0580778B1 (en) * | 1991-04-19 | 1999-08-11 | LDS Technologies, Inc. | Convertible microemulsion formulations |
GB9113872D0 (en) | 1991-06-27 | 1991-08-14 | Sandoz Ag | Improvements in or relating to organic compounds |
US6306421B1 (en) * | 1992-09-25 | 2001-10-23 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US5981568A (en) * | 1993-01-28 | 1999-11-09 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
CH686761A5 (de) * | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
US5639474A (en) * | 1993-07-01 | 1997-06-17 | Hanmi Pharm. Ind., Ltd. | Cyclosporin soft capsule composition |
JPH09510182A (ja) * | 1993-11-17 | 1997-10-14 | エルディーエス・テクノロジーズ・インコーポレーテッド | カプセル封入されたドラッグデリバリー用透明液 |
AU1911095A (en) * | 1994-02-18 | 1995-09-04 | Cephalon, Inc. | Aqueous indolocarbazole solutions |
EP0763041A1 (en) * | 1994-06-01 | 1997-03-19 | Novartis AG | Indolocarbazole derivatives for sensitizing multidrug-resistant cells to antitumor agents |
MY129435A (en) | 1994-10-26 | 2007-04-30 | Novartis Ag | Pharmaceutical microemulsion preconcentrates |
GB2308545B (en) | 1994-10-26 | 1999-06-02 | Novartis Ag | Pharmaceutical microemulsion preconcentrates |
EP0711557A1 (de) * | 1994-11-09 | 1996-05-15 | Ciba-Geigy Ag | Pharmazeutische Formulierungsgrundlage |
WO1998013032A1 (en) | 1996-09-27 | 1998-04-02 | Trega Biosciences, Inc. | Compositions of therapeutic agents suitable for oral administration |
DE19641672A1 (de) | 1996-10-10 | 1998-04-16 | Beiersdorf Ag | Kosmetische oder dermatologische Zubereitungen auf der Basis von ethylenoxidfreien und propylenoxidfreien Emulgatoren zur Herstellung von Mikroemulsionsgelen |
US5827522A (en) | 1996-10-30 | 1998-10-27 | Troy Corporation | Microemulsion and method |
NZ314060A (en) | 1997-01-13 | 1997-08-22 | Bernard Charles Sherman | Pharmaceutical microemulsion preconcentrate comprising cyclosporin dissolved in a solvent system comprising hydrophobic solvent(s) and surfactant(s) |
EP0988046B1 (en) * | 1997-01-30 | 2004-09-15 | Novartis AG | Oil-free pharmaceutical compositions containing cyclosporin a |
SI0999838T1 (en) | 1997-07-29 | 2002-08-31 | Pharmacia & Upjohn Company | Self-emulsifying formulation for lipophilic compounds |
ATE265847T1 (de) | 1997-07-29 | 2004-05-15 | Upjohn Co | Selbstemulgierbare formulierung enthaltend lipophile verbindungen |
US6346511B1 (en) * | 1997-09-08 | 2002-02-12 | Panacea Biotec Limited | Pharmaceutical composition comprising cyclosporin |
US6979456B1 (en) * | 1998-04-01 | 2005-12-27 | Jagotec Ag | Anticancer compositions |
GB9814527D0 (en) * | 1998-07-03 | 1998-09-02 | Cyclacel Ltd | Delivery system |
AR013276A1 (es) | 1998-07-31 | 2000-12-13 | Panacea Biotec Ltd | Composicion de ciclosporina transparente |
US6248363B1 (en) * | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
-
1999
- 1999-02-16 GB GBGB9903547.9A patent/GB9903547D0/en not_active Ceased
-
2000
- 2000-02-14 DK DK00909165T patent/DK1152750T3/da active
- 2000-02-14 BR BRPI0008228A patent/BRPI0008228B8/pt not_active IP Right Cessation
- 2000-02-14 CN CNB008038244A patent/CN100367930C/zh not_active Expired - Lifetime
- 2000-02-14 SI SI200031035T patent/SI1152750T1/sl unknown
- 2000-02-14 EP EP00909165A patent/EP1152750B1/en not_active Expired - Lifetime
- 2000-02-14 NZ NZ513529A patent/NZ513529A/en not_active IP Right Cessation
- 2000-02-14 AT AT00909165T patent/ATE430554T1/de active
- 2000-02-14 CA CA2362277A patent/CA2362277C/en not_active Expired - Lifetime
- 2000-02-14 RU RU2001124597/15A patent/RU2266121C2/ru active
- 2000-02-14 WO PCT/EP2000/001196 patent/WO2000048571A1/en active Application Filing
- 2000-02-14 ES ES00909165T patent/ES2326783T3/es not_active Expired - Lifetime
- 2000-02-14 ID IDW00200101649A patent/ID30504A/id unknown
- 2000-02-14 DE DE60042151T patent/DE60042151D1/de not_active Expired - Lifetime
- 2000-02-14 PE PE2000000113A patent/PE20001499A1/es not_active Application Discontinuation
- 2000-02-14 TR TR2001/02385T patent/TR200102385T2/xx unknown
- 2000-02-14 HU HU0105364A patent/HUP0105364A3/hu unknown
- 2000-02-14 SK SK1172-2001A patent/SK286967B6/sk not_active IP Right Cessation
- 2000-02-14 IL IL14451200A patent/IL144512A0/xx active IP Right Grant
- 2000-02-14 KR KR1020017009391A patent/KR100880859B1/ko active Protection Beyond IP Right Term
- 2000-02-14 JP JP2000599363A patent/JP5057610B2/ja not_active Expired - Fee Related
- 2000-02-14 AU AU31542/00A patent/AU765776B2/en active Active
- 2000-02-14 CZ CZ20012931A patent/CZ303979B6/cs not_active IP Right Cessation
- 2000-02-14 PT PT00909165T patent/PT1152750E/pt unknown
- 2000-02-14 AR ARP000100627A patent/AR022589A1/es not_active Application Discontinuation
- 2000-02-14 KR KR1020087015449A patent/KR20080064914A/ko not_active Application Discontinuation
- 2000-02-14 PL PL350556A patent/PL198330B1/pl unknown
- 2000-02-15 MY MYPI20000530A patent/MY128362A/en unknown
- 2000-03-13 TW TW089104503A patent/TWI240636B/zh not_active IP Right Cessation
-
2001
- 2001-02-14 ZA ZA200106677A patent/ZA200106677B/en unknown
- 2001-07-23 IL IL144512A patent/IL144512A/en not_active IP Right Cessation
- 2001-08-15 US US09/930,335 patent/US20020061873A1/en not_active Abandoned
- 2001-08-15 NO NO20013964A patent/NO331232B1/no not_active IP Right Cessation
-
2002
- 2002-09-13 HK HK02106758.7A patent/HK1045807B/zh not_active IP Right Cessation
-
2007
- 2007-09-21 US US11/859,077 patent/US8575147B2/en not_active Expired - Fee Related
-
2008
- 2008-07-04 EC EC2008003351A patent/ECSP083351A/es unknown
- 2008-07-07 IL IL192666A patent/IL192666A0/en unknown
-
2009
- 2009-07-31 CL CL2009001682A patent/CL2009001682A1/es unknown
-
2011
- 2011-08-05 AR ARP110102851A patent/AR082579A2/es not_active Application Discontinuation
-
2012
- 2012-01-05 JP JP2012000816A patent/JP2012111763A/ja active Pending
-
2013
- 2013-10-15 US US14/053,661 patent/US8722664B2/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0657164A1 (en) * | 1993-12-11 | 1995-06-14 | Ciba-Geigy Ag | Pharmaceutical compositions containing staurosphorine derivatives |
EP0733358A2 (de) * | 1995-03-21 | 1996-09-25 | Ciba-Geigy Ag | Intravenös applizierbare Nanosuspensionen |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100880859B1 (ko) | 자발분산성 n-벤조일-스타우로스포린 조성물 | |
AU765935B2 (en) | Substantially oil-free cyclosporin compositions | |
RU2639482C2 (ru) | Фармацевтические композиции | |
EP1082119B1 (en) | Microemulsion preconcentrates containing a piperidine substance p antagonist | |
RU2397759C2 (ru) | Микроэмульсионные композиции, включающие антагонисты вещества р | |
MXPA01008293A (en) | Spontaneously dispersible n-benzoyl staurosporine compositions | |
ZA200006597B (en) | Microemulsion preconcentrates containing a piperidine substance p antagonist. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
J201 | Request for trial against refusal decision | ||
A107 | Divisional application of patent | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130107 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140103 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20150106 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20151217 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20170102 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20180103 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20190103 Year of fee payment: 11 |
|
A101 | Application to extend term of patent right by permit | ||
FPAY | Annual fee payment |
Payment date: 20200103 Year of fee payment: 12 |